Literature DB >> 29935962

A patient with a GNAO1 mutation with decreased spontaneous movements, hypotonia, and dystonic features.

Akihisa Okumura1, Koichi Maruyama2, Mami Shibata3, Hirokazu Kurahashi4, Atsushi Ishii5, Shingo Numoto6, Shinichi Hirose5, Tomoko Kawai7, Manami Iso8, Shinsuke Kataoka9, Yusuke Okuno10, Hideki Muramatsu9, Seiji Kojima9.   

Abstract

We report on a 4-year-old girl with a de novo GNAO1 mutation who had neurological findings, including decreased spontaneous movements, hypotonia, and dystonic features. She was referred to our hospital because of delayed psychomotor development. She showed hypotonia and decreased spontaneous movements. Voluntary movements of the limbs were more frequent in the lower extremities than in the upper extremities. Occasional dyskinetic features, such as awkward hand/foot posturing and grimacing, were seen during the voluntary movements. Serum metabolic screening, head magnetic resonance imaging, and electroencephalography were unremarkable. Whole-exome sequencing revealed a de novo mutation in the patient's GNAO1 gene, c.709 G > A (p.E237K). We calculated the free-energy change using the FoldX Suite to evaluate the impact of the E237K mutation. The FoldX calculations showed an increased free-energy change in the active state of the GNAO1 protein, indicating that the E237K mutation destabilizes the active state complexes. No seizures, chorea, tremor, or myoclonia, which are frequently reported in patients with GNAO1 mutations, were observed as of the last follow up. Our patient will improve the understanding of early neurological features in patients with GNAO1 mutations.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Decreased spontaneous movement; Dystonic features; GNAO1; Hypotonia

Mesh:

Substances:

Year:  2018        PMID: 29935962     DOI: 10.1016/j.braindev.2018.06.005

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

1.  Deep brain stimulation in a young child with GNAO1 mutation - Feasible and helpful.

Authors:  Eva Lai-Wah Fung; Chung-Yin Mo; Sharon Tsui-Hang Fung; Anne Yin-Yan Chan; Ka-Yee Lau; Emily Kit-Ying Chan; David Yuen-Chung Chan; Xian-Lun Zhu; Danny Tat-Ming Chan; Wai-Sang Poon
Journal:  Surg Neurol Int       Date:  2022-07-01

2.  Both subthalamic and pallidal deep brain stimulation are effective for GNAO1-associated dystonia: three case reports and a literature review.

Authors:  Ye Liu; Qingping Zhang; Jun Wang; Jiyuan Liu; Wuyang Yang; Xuejing Yan; Yi Ouyang; Haibo Yang
Journal:  Ther Adv Neurol Disord       Date:  2022-04-29       Impact factor: 6.430

3.  GNAO1 as a Novel Predictive Biomarker for Late Relapse in Hepatocellular Carcinoma.

Authors:  Meiling Du; Jie Feng; Yiran Tao; Qincong Pan; Fengyuan Chen
Journal:  J Healthc Eng       Date:  2021-11-30       Impact factor: 2.682

4.  Treating GNAO1 mutation-related severe movement disorders with oxcarbazepine: a case report.

Authors:  Weihao Ling; Danping Huang; Fan Yang; Zuozhen Yang; Min Liu; Qiujiao Zhu; Jing Huang; Rui Zhou; Xuqin Chen
Journal:  Transl Pediatr       Date:  2022-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.